Related Experiment Video
Updated: Aug 23, 2026

Intracameral Injection in Rats with Low Risk of Adverse Effects
Published on: May 31, 2024
[Antimicrobial agents in eyedrops]
1Katedra farmaceutické technologie Farmaceutické fakulty Univerzity Karlovy, Hradec Králové. sklubalo@faf.cuni.cz
Abstract:
Microbial contamination of ophthalmic drops means a risk of serious injury to the eye. Ophthalmic drops must therefore comply with sterility requirements. Protection of multiple-dose drops against secondary contamination is ensured by an addition of an antimicrobial agent. Selection of a suitable antimicrobial agent is conditioned by many factors, such as the spectrum of effect, properties of the preparation, compatibility with the components of the preparation and the container, and the technology of manufacture. Although the added antimicrobial substance ensures the safety of the preparation, on the other hand it can produce a number of negative effects in the eye tissue. The present paper summarizes pharmacopoeial requirements for microbial quality of ophthalmic drops, outlining the properties and efficacy of antimicrobial substances commonly used in ophthalmic drops (benzalkonium chloride BAC, cetrimide CTM, phenyl mercuric salts PHg, thiomersal TM, chlorobutanol ChB, benzyl alcohol BA, phenyl ethyl alcohol PEA, chlorohexidin ChX, parabens PB), their typical concentrations and combinations, including the parameters of formulation and the interactions which affect their activity. It deals with the toxicity of these antimicrobial substances, side effects on the eye tissue, and alternatives to the use of antimicrobial agents.
Insights
Ophthalmic drops require antimicrobial agents to prevent contamination, but these agents can harm eye tissues. This review examines antimicrobial properties, efficacy, and toxicity for safer eye drop formulations.
Area of Science:
- Pharmaceutical Microbiology
- Ophthalmology
- Drug Formulation
Context:
- Microbial contamination of ophthalmic preparations poses a significant risk of severe ocular injury.
- Sterility is a critical requirement for all ophthalmic drops to ensure patient safety.
- Multidose ophthalmic products require antimicrobial agents to prevent secondary microbial contamination.
Purpose:
- To summarize pharmacopoeial standards for the microbial quality of ophthalmic drops.
- To review the properties, efficacy, and typical concentrations of common antimicrobial agents used in ophthalmic solutions.
- To discuss the toxicity and ocular side effects associated with these antimicrobial agents and explore alternatives.
Summary:
- The paper details pharmacopoeial requirements for ophthalmic drop sterility.
- It outlines key antimicrobial agents (e.g., benzalkonium chloride, parabens) used in eye drops, their characteristics, concentrations, and interactions.
- The review also covers the toxicological profiles and adverse effects of these preservatives on ocular tissues.
Impact:
- Informs the selection of appropriate antimicrobial agents for ophthalmic formulations to balance efficacy and ocular safety.
- Highlights the need for careful consideration of preservative toxicity and potential side effects in eye drop development.
- Guides the development of safer ophthalmic products by exploring alternative preservation strategies.
Related Concept Videos
Antimicrobial Effectiveness
Chemical Agents for Microbial Control
Microbiome of the Eye
Hand hygiene
Hand washing...
Ophthalmic Drug Delivery Systems
Antifungal Agents

